Exam 3 Anti-retroviral therapy Flashcards
What are some therapeutic implications of HAART?
- Inhibit RTase (cytoplasmic)
- Inhibit integrase (nuclear)
- Inhibit protease (cytoplasmic)
Anti-retroviral therapy drugs approved by FDA (5)
- Reverse transcriptase inhibitors (RTI)
- Protease inhibitors
- Fusion and entry inhibitors
- Integrase inhibitors
- Pharmacokinetic enhancers
What is a NRTI?
Nucleoside reverse transcriptase inhibitor
NRTI’s are _____ analogs
Nucleoside
First generation NRTI’s are not ____ specific
Viral DNA polymerase (RT)
First NRTI’s introduced
- Azidothymidine (AZT)
- Zidovudine (ZDV)
Functions of NRTI’s
- chain terminators
- block RTase
What are NNRTI’s?
Non-nucleoside reverse transcriptase inhibitors
What do NNRTI’s do?
- Allosteric “non-competitive” inhibition
- Bind to binding site, not enzyme active site
NNRTI’s are synergistic with ____
NRTI’s
Characteristics of protease inhibitors
- Synthetic peptide
- Non-hydrolysable
- stable
What is the function of protease inhibitors?
Block HIV protease (polyprotein cleavage)
What does integrase inhibitor do?
Inhibits irreversible strand transfer step of DNA integration
Raltegravir is an example of:
Integrase inhibitor
Integrase inhibitors are metabolized by:
Cellular glucuronidation
Dolutegravir is an example of:
Integrase inhibitor
____ (integrase inhibitor) was approved in August 2013. It has a prolonged intracellular half life
Dolutegravir
Elvitegravir (EVG) is an example of:
Integrase inhibitor
Elvitegravir is also called:
Vitekta
____ (integrase inhibitor) was approved in September 24, 2014
Elvitegravir
______ is the newest integrase inhibitor (Jan 22, 2021)
Cabotegravir
Examples of pharmacokinetic enhancers
- Cobicistat (COBI); Tyboost
- P450 CYP3A4 enzyme inhibitor
A new attachment inhibitor called _____ binds to ____
Fostemsavir; gp120
Enfuviritide is an example of:
Fusion inhibitor
Enfuviritide binds to ____
gp41